Merit Medical Systems Inc (MMSI)
105.33
+0.30
(+0.29%)
USD |
NASDAQ |
Nov 22, 16:00
105.39
+0.06
(+0.06%)
After-Hours: 20:00
Merit Medical Systems Cash from Financing (Quarterly): -47.57M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -47.57M |
| June 30, 2024 | 3.137M |
| March 31, 2024 | -18.00M |
| December 31, 2023 | 472.81M |
| September 30, 2023 | -54.55M |
| June 30, 2023 | 141.51M |
| March 31, 2023 | -0.497M |
| December 31, 2022 | -5.749M |
| September 30, 2022 | -27.07M |
| June 30, 2022 | -13.20M |
| March 31, 2022 | -14.24M |
| December 31, 2021 | -32.47M |
| September 30, 2021 | -17.89M |
| June 30, 2021 | -21.83M |
| March 31, 2021 | -26.25M |
| December 31, 2020 | -4.548M |
| September 30, 2020 | -51.98M |
| June 30, 2020 | -32.95M |
| March 31, 2020 | -6.234M |
| December 31, 2019 | -0.167M |
| September 30, 2019 | 25.94M |
| June 30, 2019 | 17.58M |
| March 31, 2019 | -9.821M |
| December 31, 2018 | 187.92M |
| September 30, 2018 | 2.239M |
| Date | Value |
|---|---|
| June 30, 2018 | 28.62M |
| March 31, 2018 | 109.50M |
| December 31, 2017 | 0.809M |
| September 30, 2017 | 38.06M |
| June 30, 2017 | 6.923M |
| March 31, 2017 | 50.72M |
| December 31, 2016 | -2.441M |
| September 30, 2016 | 98.82M |
| June 30, 2016 | 3.526M |
| March 31, 2016 | 21.20M |
| December 31, 2015 | -2.747M |
| September 30, 2015 | 1.504M |
| June 30, 2015 | -1.715M |
| March 31, 2015 | -7.277M |
| December 31, 2014 | -11.76M |
| September 30, 2014 | -8.238M |
| June 30, 2014 | -3.287M |
| March 31, 2014 | 6.314M |
| December 31, 2013 | -0.946M |
| September 30, 2013 | -5.239M |
| June 30, 2013 | 2.911M |
| March 31, 2013 | 18.04M |
| December 31, 2012 | 170.48M |
| September 30, 2012 | 11.31M |
| June 30, 2012 | 4.583M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-54.55M
Minimum
Sep 2023
472.81M
Maximum
Dec 2023
12.11M
Average
-16.07M
Median
Cash from Financing (Quarterly) Benchmarks
| Becton Dickinson & Co | 124.00M |
| Boston Scientific Corp | 7.00M |
| ResMed Inc | -150.76M |
| Abbott Laboratories | -1.576B |
| Baxter International Inc | -146.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 47.33M |
| Cash from Investing (Quarterly) | -115.67M |
| Free Cash Flow | 172.71M |
| Free Cash Flow Per Share (Quarterly) | 0.6284 |
| Free Cash Flow to Equity (Quarterly) | 88.23M |
| Free Cash Flow to Firm (Quarterly) | 38.07M |
| Free Cash Flow Yield | 2.79% |